Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIITerminatedApr 19, 2017Fluocinolone Acetonide Topical Solution USP 0.01% For Topical Use OnlyChemical ContaminationNovel Laboratories, Inc. · D-0653-2017Class IIITerminatedApr 19, 2017Penicillin V Potassium TabletsPresence of Foreign Tablet/Capsule; Amoxicillin 500 mg was found in bottles of Penicillin V potassium 500 mgCitron Pharma Llc · D-0652-2017Class IIITerminatedApr 19, 2017Doxercalciferol Capsules 0.5mcgFailed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.West-Ward Columbus, Inc. · D-0651-2017Class IIITerminatedApr 12, 2017Quinapril Tablets USP 5 mgFailed Impurities/Degradation Specifications; Impurity ALupin Pharmaceuticals Inc. · D-0650-2017Class IIITerminatedApr 12, 2017RIVASTIGMINE Tartrate CapsulesCross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.Dr. Reddy's Laboratories, Inc. · D-0649-2017Class IITerminatedApr 12, 2017CotellicSuperpotent Drug: An oversized tablet was found in a bottle.Genentech Inc. · D-0648-2017Class IIITerminatedApr 12, 2017Fluphenazine Decanoate InjectionSubpotent DrugFresenius Kabi USA, LLC · D-0647-2017Class ITerminatedApr 12, 2017XtraHRD Natural Male Enhancement CapsulesMarketed without an Approved NDA/ANDA: Product contains N-desmethyl tadalafil an analogue to tadalafil which is an active pharmaceutical ingredient in a FDA approved...Organic Herbal Supply · D-0646-2017Class ITerminatedApr 12, 2017Vancomycin HCl 750 mg added to 5% Dextrose 250 mL For IV Use OnlyPresence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.SCA Pharmaceuticals · D-0645-2017Class ITerminatedApr 12, 2017Vancomycin HCl 750 mg added to 250 mL 0.9% Sodium Chloride For IV Use OnlyPresence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.SCA Pharmaceuticals · D-0644-2017Class ITerminatedApr 12, 2017Vancomycin HCl 1.5 gram added to 5% Dextrose 500 mL Total Approximate Volume 515 mL For IV Use OnlyPresence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.SCA Pharmaceuticals · D-0643-2017Class ITerminatedApr 12, 2017Vancomycin HCl 1.5 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use OnlyPresence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.SCA Pharmaceuticals · D-0642-2017Class ITerminatedApr 12, 2017Vancomycin HCl 1.25 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use OnlyPresence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.SCA Pharmaceuticals · D-0641-2017Class ITerminatedApr 12, 2017Vancomycin HCl 1 g added to 0.9% Sodium Chloride 250 mL Bag For IV Use OnlyPresence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.SCA Pharmaceuticals · D-0640-2017Class ITerminatedApr 12, 2017Vancomycin HCl 1.25 g added to 5% Dextrose 250 mL Bag For IV Use OnlyPresence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.SCA Pharmaceuticals · D-0639-2017Class ITerminatedApr 12, 2017Vancomycin Hydrochloride for InjectionPresence of Particulate Matter: A hair was found stuck to the stopper of inside a single vial. The hair came in contact with the reconstituted drug product.Hospira Inc., A Pfizer Company · D-0638-2017Class ITerminatedApr 12, 2017Ibuprofen Lysine InjectionPresence of Particulate MatterX-Gen Pharmaceuticals Inc. · D-0637-2017Class IIITerminatedApr 12, 2017Ciclopirox Olamine Cream USPLabeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.G & W Laboratories, Inc. · D-0636-2017Class IIITerminatedApr 12, 2017Adalat CCCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0635-2017Class IIITerminatedApr 12, 2017Adalat CCCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0634-2017Class IIITerminatedApr 12, 2017Adalat CCCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0633-2017Class IIITerminatedApr 12, 2017Adalat CCCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0632-2017Class IIITerminatedApr 12, 2017Nifedipine Extended-Release TabletsCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0631-2017Class IIITerminatedApr 12, 2017Nifedipine Extended-Release TabletsCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0630-2017Class IIITerminatedApr 12, 2017Adalat CCCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0629-2017Class IIITerminatedApr 12, 2017Adalat CCCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0628-2017Class IIITerminatedApr 12, 2017Nifedipine Extended-Release TabletsCross Contamination with another product:residual powder found in inlet air duct identified as sorafenibAlvogen, Inc · D-0627-2017Class IIOngoingApr 12, 2017Ventolin HFADefective Delivery System: Elevated number of units with out of specification results for leak rate.GlaxoSmithKline, LLC · D-0626-2017Class IITerminatedApr 12, 2017KalbitorPresence of Particulate Matter: GlassShire · D-0625-2017Class IITerminatedApr 5, 2017Sensodyne Repair & Protect WhiteningPresence of Foreign Substance; low concentration of an additional flavoring ingredient, Patchouli oil resulting in complaints of off flavor/scentGSK Consumer Healthcare · D-0624-2017Class IIITerminatedApr 5, 2017Montelukast sodium tabletsDiscoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle.Hetero USA Inc · D-0623-2017Class IITerminatedApr 5, 2017Atorvastatin Calcium TabletsMicrobial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · D-0622-2017Class IITerminatedApr 5, 2017Atorvastatin Calcium TabletsMicrobial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.Mylan Pharmaceuticals Inc. · D-0621-2017Class IITerminatedApr 5, 2017Atorvastatin Calcium TabletsMicrobial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.Mylan Pharmaceuticals Inc. · D-0620-2017Class IITerminatedApr 5, 2017Atorvastatin Calcium TabletsMicrobial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.Mylan Pharmaceuticals Inc. · D-0619-2017Class IITerminatedApr 5, 2017Atorvastatin Calcium TabletsMicrobial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.Mylan Pharmaceuticals Inc. · D-0618-2017Class IITerminatedApr 5, 2017Divalproex Sodium Delayed Release TabletsFailed Dissolution Specifications; 9 month long term stabilityZydus Pharmaceuticals USA Inc · D-0617-2017Class IITerminatedApr 5, 2017Metronidazole InjectionLack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the...Claris Lifesciences Inc · D-0616-2017Class IITerminatedApr 5, 2017Levofloxacin Injection in 5% DextroseLack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the...Claris Lifesciences Inc · D-0615-2017Class IITerminatedApr 5, 2017Fluconazole InjectionLack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the...Claris Lifesciences Inc · D-0614-2017

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.